GENEVA, Jan. 26 -- TIANJIN MEDICAL UNIVERSITY (No.22, Qixiangtai RoadHeping District, Tianjin 300070), 天津医科大学 (中国天津市和平区气象台路22号) filed a patent application (PCT/CN2025/109129) for "USE OF ARTIFICIALLY DESIGNED NOVEL NRG-1 IN DISEASE TREATMENT" on Jul 17, 2025. With publication no. WO/2026/017126, the details related to the patent application was published on Jan 22, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): CHEN, Xiongwen (No.22, Qixiangtai RoadHeping Dist...